An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
Recap by typeshit. Full story at The Daily Cougar.
She talks with Annika Urban about combining GLP-1 treatment with behavioral coaching and telehealth care.
Oddo moved to DKK 305 and HSBC to DKK 280. Novo also shared a CagriSema subgroup analysis showing women lost 25% of body weight at 68 weeks.
MUSC Health suggests the familiar ABCs of heart health may change, with GLP-1 medications now part of cardiovascular prevention for some patients.
Bauer, who has a PhD in neuroscience and endocrinology, joins Geller to discuss insulin resistance and the shame many women feel about their weight.
The REDEFINE 1 data covered 2,309 women, with placebo at 3%. In the REDEFINE 4 head-to-head, tirzepatide matched or slightly beat it.
8:58
Constable, who bills herself as a peptide expert, lists side effects she links to the unapproved triple agonist. Her claims, not trial data, so weigh them accordingly.
Loading…